“…New semi‐automated cell assays have been applied with some success to melanoma as well as other solid tumors for the purpose of diagnosing LMD (Le Rhun, Tu, et al, ; Lin et al, , #1447). In the largest cohort ( n = 95, 36 breast, 31 lung, 28 others) to date, a cutoff of ≥1 CSF‐CTC/ml provided the best threshold to diagnose LMD, achieving a sensitivity of 93%, specificity of 95%, positive predictive value 90%, and negative predictive value 97% (Lin et al, ). Other methods, such as flow cytometry, have proved disappointing due to inconsistent surface marker expression.…”